Braveheart Bio, Inc. BRVE
Set alert
21.33 USD +0.29 +1.35%
As of Nov 3, 11:35 AM ET
20.24 Day range 21.51
17.86 52-week range 32.00
- YTD
- -28.44%
- 1 year
- -28.44%
- Open
- 20.94
- Prev close
- 21.04
- Mkt cap
- 1.92B
- Vol
- 24.45K
- Avg vol
- 477.30K
- EPS
- -6.08
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 20.24
- High
- 21.51
- Forward P/E
- -10.57
- Beta
- 0.00
- Short ratio
- 8.11
- Inst. own
- 28.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 8, 2026
- 50-d avg
- 23.52
- 200-d avg
- 24.23
- 1y target
- 45.25
MAX chart
Events in this range
- Sep 8, 2026Earnings: -2.51; estimate 2.69; surprise -193.31%
- Oct 20, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
Signals (175)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 30, 2026 | 3 days ago |
| SMA: Bearish | Oct 29, 2026 | 5 days ago |
| SMA: Bearish | Oct 29, 2026 | 5 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 28, 2026 | 6 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 28, 2026 | 6 days ago |
| SMA: Bullish | Oct 27, 2026 | 1 week ago |
| SMA: Bearish | Oct 27, 2026 | 1 week ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
Newest 20 of 175.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 45.25 +112.2% upside
Now 21.33
- Target (low)
- 40.00
- Target (mean)
- 45.25
- Target (high)
- 48.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy0
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.438 | -0.91 – -0.21 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Next quarter | -0.284 | -0.47 – 0.35 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Current year | -1.78 | -2.94 – -0.65 | -17.21 | +89.7% | 0 | 0.0% | 5 |
| Next year | -1.62 | -2.34 – -1.10 | -1.78 | +8.9% | 0 | 0.0% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |